LifeTech Scientific Corporation (01302.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.5x

Market Cap

HKD 6.05B

MomentumView details →

1D Return

+2.59%

YTD Return

−11.22%

RSI (14)

48.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.5x

Market Cap

HKD 6.05B

RSI (14)

48.6

MomentumView details →

1D Return

+2.59%

YTD Return

−11.22%

ProfitabilityView details →

Gross Margin

74.42%

Net Margin

5.00%

EBITDA Margin

15.71%

ROE (TTM)

3.94%

ROA (TTM)

2.75%

Asset Turnover

0.54x

GrowthView details →

Revenue YoY

+6.14%

EPS YoY

−77.45%

FCF YoY

+187.50%

Revenue CAGR 3Y

+7.67%

EPS CAGR 3Y

−24.61%

EBITDA YoY

−47.42%

EarningsView details →

EPS (Actual)

−HKD 0.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.45x

Quick Ratio

1.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

2.61B

Net Income (TTM)

130.78M

Op. CF (TTM)

—

Next earningsMar 31, 2027 →

Latest newsMore news →

Lifetech Scientific announced the termination of its proposed acquisition of Huayi Medical equity and the related convertible bond issuance, after negotiations failed to reach an agreement.46d ago

Similar companies

浩欧博688656.SH AK Medical Holdings Limited01789.HK 春立医疗688236.SH Zylox-Tonbridge Medical Technology Co., Ltd.02190.HK 赛诺医疗688108.SH 新华医疗600587.SH Find similar companies →

Latest newsMore news →

Lifetech Scientific announced the termination of its proposed acquisition of Huayi Medical equity and the related convertible bond issuance, after negotiations failed to reach an agreement.46d ago